-+ 0.00%
-+ 0.00%
-+ 0.00%

Revolution Medicines Chief Global Commercialization Officer Anthony Mancini disposes of common shares; $3,542,000 drops from sales on March 25, 2026

路透·03/27/2026 00:04:43

登錄查看新聞詳情